| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 100.104 | 75 |
| GSM780708 | Untreated after 4 days (C2_1) | 95.309 | 75 |
| GSM780709 | Untreated after 4 days (C3_1) | 91.9676 | 74 |
| GSM780719 | Untreated after 4 days (C1_2) | 93.8274 | 74 |
| GSM780720 | Untreated after 4 days (C2_2) | 132.666 | 79 |
| GSM780721 | Untreated after 4 days (C3_2) | 125.688 | 78 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 107.803 | 76 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 107.133 | 76 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 98.3958 | 75 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 117.503 | 77 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 97.6559 | 75 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 86.5785 | 73 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 115.09 | 77 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 106.255 | 76 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 103.718 | 76 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 105.559 | 76 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 116.513 | 77 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 87.4416 | 73 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 108.771 | 76 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 116.451 | 77 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 130.733 | 79 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 105.846 | 76 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 90.3167 | 74 |